321 related articles for article (PubMed ID: 14666364)
21. Adaptation of Insulin Clearance to Metabolic Demand Is a Key Determinant of Glucose Tolerance.
Gastaldelli A; Abdul Ghani M; DeFronzo RA
Diabetes; 2021 Feb; 70(2):377-385. PubMed ID: 33077684
[TBL] [Abstract][Full Text] [Related]
22. [Simple methods for evaluating insulin resistance and pancreatic beta-cell function in hypertensive metabolic syndrome].
Shanghai Optimal Diagnosis and Therapy in Hypertensives with Insulin Resistance Cooperative Group
Zhonghua Nei Ke Za Zhi; 2005 Mar; 44(3):169-72. PubMed ID: 15840252
[TBL] [Abstract][Full Text] [Related]
23. [Associations of insulin resistance and pancreatic beta-cell function with plasma glucose level in type 2 diabetes].
Nian X; Sun G; Dou C; Hou H; Fan X; Yu H; Ma L; He B
Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):732-5. PubMed ID: 12126540
[TBL] [Abstract][Full Text] [Related]
24. Glucose Homeostatic Law: Insulin Clearance Predicts the Progression of Glucose Intolerance in Humans.
Ohashi K; Komada H; Uda S; Kubota H; Iwaki T; Fukuzawa H; Komori Y; Fujii M; Toyoshima Y; Sakaguchi K; Ogawa W; Kuroda S
PLoS One; 2015; 10(12):e0143880. PubMed ID: 26623647
[TBL] [Abstract][Full Text] [Related]
25. Relationship between insulin resistance and left ventricular diastolic dysfunction in patients with impaired glucose tolerance and type 2 diabetes.
Bajraktari G; Koltai MS; Ademaj F; Rexhepaj N; Qirko S; Ndrepepa G; Elezi S
Int J Cardiol; 2006 Jun; 110(2):206-11. PubMed ID: 16297997
[TBL] [Abstract][Full Text] [Related]
26. Comparison of three methods for the quantification of beta-cell function and insulin sensitivity.
Nijpels G; van der Wal PS; Bouter LM; Heine RJ
Diabetes Res Clin Pract; 1994 Dec; 26(3):189-95. PubMed ID: 7736899
[TBL] [Abstract][Full Text] [Related]
27. Beta- and alpha-cell dysfunction in subjects developing impaired glucose tolerance: outcome of a 12-year prospective study in postmenopausal Caucasian women.
Ahrén B
Diabetes; 2009 Mar; 58(3):726-31. PubMed ID: 19095762
[TBL] [Abstract][Full Text] [Related]
28. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
[TBL] [Abstract][Full Text] [Related]
29. Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease.
Arslanian SA; Lewy VD; Danadian K
J Clin Endocrinol Metab; 2001 Jan; 86(1):66-71. PubMed ID: 11231980
[TBL] [Abstract][Full Text] [Related]
30. Roles of insulin resistance and beta-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis.
Austin A; Kalhan SC; Orenstein D; Nixon P; Arslanian S
J Clin Endocrinol Metab; 1994 Jul; 79(1):80-5. PubMed ID: 8027259
[TBL] [Abstract][Full Text] [Related]
31. Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus.
Guerrero-Romero F; Rodríguez-Morán M
Eur J Clin Invest; 2006 Nov; 36(11):796-802. PubMed ID: 17032347
[TBL] [Abstract][Full Text] [Related]
32. [Characteristics of dysfunction of islet beta-cell in newly diagnosed type 2 diabetic patients].
Li YB; Zhu DL; Tian HM; Shi LX; Luo ZJ; Yan L; Zeng LY; Zhou ZG; Yang LY; Liu J; Li M; Weng JP
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2537-41. PubMed ID: 17198561
[TBL] [Abstract][Full Text] [Related]
33. Progression from impaired glucose tolerance to type 2 diabetes in obese children and adolescents: a 3-6-year cohort study in southern Thailand.
Jaruratanasirikul S; Thammaratchuchai S; Puwanant M; Mo-Suwan L; Sriplung H
J Pediatr Endocrinol Metab; 2016 Nov; 29(11):1267-1275. PubMed ID: 27740930
[TBL] [Abstract][Full Text] [Related]
34. Decreased beta cell function and insulin sensitivity contributed to increasing fasting glucose in Chinese.
Bi Y; Zhu D; Jing Y; Hu Y; Feng W; Shen S; Tong G; Shen X; Yu T; Song D; Yang D
Acta Diabetol; 2012 Dec; 49 Suppl 1():S51-8. PubMed ID: 20473530
[TBL] [Abstract][Full Text] [Related]
35. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
[TBL] [Abstract][Full Text] [Related]
36. Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations.
Ahrén B; Larsson H
Diabetologia; 2001 Nov; 44(11):1998-2003. PubMed ID: 11719830
[TBL] [Abstract][Full Text] [Related]
37. Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes.
Okuno Y; Komada H; Sakaguchi K; Nakamura T; Hashimoto N; Hirota Y; Ogawa W; Seino S
Metabolism; 2013 Oct; 62(10):1470-6. PubMed ID: 23831440
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.
Miyazaki Y; Pipek R; Mandarino LJ; DeFronzo RA
Int J Obes Relat Metab Disord; 2003 Jan; 27(1):88-94. PubMed ID: 12532159
[TBL] [Abstract][Full Text] [Related]
39. Determinants for the progression from impaired glucose tolerance to non-insulin-dependent diabetes mellitus.
Nijpels G
Eur J Clin Invest; 1998 Sep; 28 Suppl 2():8-13. PubMed ID: 9777321
[TBL] [Abstract][Full Text] [Related]
40. Insulin secretion and insulin sensitivity in people with impaired glucose tolerance.
Pimenta W; Mitrakou A; Jensen T; Yki-Järvinen H; Daily G; Gerich J
Diabet Med; 1996 Sep; 13(9 Suppl 6):S33-6. PubMed ID: 8894478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
